Max Healthcare Institute's subsidiary, Alps Hospital, has been served a GST demand notice for Rs 165.71 crore by DGGI. The dispute concerns management fees and includes substantial penalties. The company is actively contesting the allegations.
Max Healthcare Subsidiary Hit with Rs 165 Crore GST Notice
Total demand excluding interest stands at Rs 165.71 crore across three liability components.
Alps Hospital Limited has received a show-cause notice from the Directorate General of Goods & Services Tax Intelligence.
Reader Takeaway: Regulatory tax dispute regarding management fees creates potential financial liability while company prepares formal defense.
What just happened
Max Healthcare Institute informed the exchange that its wholly-owned subsidiary, Alps Hospital Limited, received a show-cause cum demand notice from the Mumbai Zonal Unit of the DGGI on August 25, 2026. The authorities have raised concerns regarding the non-payment of GST on variable management fees charged by the entity.
Financial Exposure
The regulatory authority has sought a total payment of Rs 165.71 crore, excluding interest. This includes the alleged tax demand of Rs 55.24 crore and two additional penalty components under the CGST Act, each amounting to Rs 55.24 crore. The final financial impact remains subject to the adjudication process.
What changes now
The management of Max Healthcare has officially stated that the company is in the process of drafting and filing detailed submissions to contest the demand. As the matter is now in the initial legal stage, no immediate financial outflow is required. The company's legal and tax teams are reviewing the notice to formulate their strategy.
Risks to watch
Investors should monitor the progression of this litigation. Any adverse order from the tax authorities could impact the company's short-term cash flow and balance sheet. Additionally, the accumulation of interest on the base demand remains an uncapped variable that could increase the total liability over time.
What to track next
Shareholders should look for future exchange filings regarding the company's response to the DGGI and any subsequent hearing dates or show-cause proceedings.
